Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s release/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a change in the ClinicalTrials.gov page revision, not the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T05:39:25.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:20:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Hurthle cell carcinoma of thyroid and differentiated thyroid carcinoma to the conditions, and included a Resources section with the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T14:52:31.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No user-facing content or functionality is affected.
    Difference
    0.0%
    Check dated 2026-03-18T21:56:12.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a metadata version change and does not modify core content such as study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-03-11T18:55:19.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Site footer updated to Revision: v3.4.2; the government funding-lapse notice and the older Revision: v3.4.1 label were removed.
    Difference
    0.4%
    Check dated 2026-02-11T10:30:57.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.